Bain Capital Life Sciences Investors, LLC
Position in SLDB — Solid Biosciences Inc.
CIK 1703031
Boston, MA
Position in SLDB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$97,990,101
+$27,366,605 QoQ
Shares Held
9,808,819
0.0% QoQ
Ownership
9.15%
of shares outstanding
% of Portfolio
5.83%
of 13F equity value
Holder Rank
#3
of 155 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLDB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bain Capital Life Sciences Investors, LLC holds $1,318,022,438 across 17 Biotechnology names. SLDB ranks #4 (7.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | KLRA |
Kailera Therapeutics, Inc.
|
22,583,268 | $497,509,394 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
3,906,565 | $131,141,499 | |
| 3 | SVRA |
Savara Inc
|
17,600,621 | $108,419,825 | |
| 4 | SLDB |
Solid Biosciences Inc.
This page
|
9,808,819 | $97,990,101 | |
| 5 | PHVS |
Pharvaris N.V.
|
2,675,509 | $92,519,101 | |
| 6 | OLMA |
Olema Pharmaceuticals, Inc.
|
7,085,249 | $88,636,464 | |
| 7 | COAG |
Hemab Therapeutics Holdings, Inc.
|
1,650,000 | $60,604,500 | |
| 8 | CABA |
Cabaletta Bio, Inc.
|
17,241,445 | $53,620,893 |
All Filings in SLDB
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $97,990,101 | 9,808,819 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $70,623,496 | 9,808,819 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,621,813 | 7,911,669 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $48,814,997 | 7,911,669 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,529,828 | 7,911,669 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $29,273,175 | 7,911,669 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $16,138,328 | 4,034,582 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $28,121,036 | 4,034,582 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $22,876,079 | 4,034,582 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $53,740,632 | 4,034,582 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $19,220,791 | 3,130,422 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $7,888,663 | 3,130,422 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $16,403,411 | 3,130,422 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $14,838,200 | 3,130,422 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $16,841,670 | 3,130,422 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,703,271 | 7,929,918 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $4,884,829 | 7,929,918 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $9,515,901 | 7,929,918 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $13,877,356 | 7,929,918 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $18,952,504 | 7,929,918 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $29,023,499 | 7,929,918 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $43,852,446 | 7,929,918 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $53,517,475 | 7,060,353 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $7,858,462 | 3,871,164 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $11,342,510 | 3,871,164 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $9,252,081 | 3,871,164 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||